In vitro examination of the thrombolytic efficacy of tenecteplase and therapeutic ultrasound compared to rt-PA

BMC Neurology

Table 1 Values of lysis experiments as depicted in Fig. 3 and TEM experiments as depicted in Fig. 4

	A control	B rt-PA	C rt-PA + US	D TNK	E TNK + US
weight loss ± SD [%]	17.3 ± 7.4	28.3 ± 9.6	31.6 ± 10	34.5 ± 8	38.1 ± 6.7
area covered by fibrin ± SD [%]	58 ± 5.2	54.7 ± 3.6	52.9 ± 6.5	42.3 ± 6	45.1 ± 2.3

Results for measured relative clot weight loss of different treatment groups (A-E) as well as for relative area covered by fibrin in TEM for the different treatment strategies are combined. SD: standard deviation from the mean. TNK: tenecteplase; US: color-coded sonography (2 MHz, 0.179 W/cm²)

ISSN: 1471-2377